Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,317 | 8,335 | 8,173 | 5,192 | 5,596 |
| Receivables | 17,766 | 20,704 | 21,463 | 17,091 | 19,921 |
| Inventories | 22,262 | 22,061 | 25,087 | 16,848 | 19,955 |
| Other current assets | 3,355 | 2,472 | 3,109 | 8,404 | 0 |
| TOTAL | $51,700 | $53,572 | $57,832 | $47,535 | $45,472 |
| Non-Current Assets | |||||
| PPE Net | 3,960 | 4,776 | 5,898 | 3,743 | 4,296 |
| Intangibles | 91,741 | 95,786 | 103,068 | 47,610 | 18,680 |
| Other Non-Current Assets | 8,853 | 10,736 | 1,815 | 10,466 | 39,317 |
| TOTAL | $104,554 | $111,298 | $110,781 | $61,819 | $62,293 |
| Total Assets | $156,254 | $164,870 | $168,613 | $109,354 | $107,765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,721 | 6,900 | 5,982 | 2,765 | 2,372 |
| Accounts payable and accrued liabilities | 5,972 | 5,339 | 7,359 | 4,410 | 6,196 |
| Accrued Expenses | N/A | N/A | 978 | 4,211 | 4,773 |
| Other current liabilities | 7,478 | 6,700 | 7,350 | 2,150 | 760 |
| TOTAL | $21,053 | $25,312 | $25,489 | $14,041 | $14,601 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46,286 | 46,917 | 54,813 | 8,983 | 11,374 |
| Deferred Revenues | 3,771 | 3,949 | 3,820 | 505 | 500 |
| Other Non-Current Liabilities | 10,335 | 8,973 | 3,286 | 2,777 | 3,177 |
| TOTAL | $58,520 | $57,864 | $60,400 | $14,413 | $20,968 |
| Total Liabilities | $79,573 | $83,176 | $85,889 | $28,454 | $35,569 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,983 | 3,835 | 3,767 | 3,559 | 3,458 |
| Common Shares | 444 | 438 | 436 | 419 | 418 |
| Retained earnings | -132,386 | -124,576 | -119,889 | -116,967 | -116,030 |
| Other shareholders' equity | -12,734 | -12,357 | -13,200 | -10,344 | -16,326 |
| TOTAL | $76,681 | $81,694 | $82,724 | $80,900 | $72,196 |
| Total Liabilities And Equity | $156,254 | $164,870 | $168,613 | $109,354 | $107,765 |